Stock Research: Convatec Group

Peer-based, data-driven stock research by Obermatt enables quick and easy due diligence for your stock investing.

What's New

Recent improvements to enhance your investment research experience

360° View free for everyone

Our most comprehensive analysis—the 360° View—is now free for everyone. To maintain our research quality, other ranks are now part of our new subscription plans.

3 new subscription models

Plans for every investor - from stock ideas to in-depth analysis.

Similar Stocks

Four stock alternatives to the stock you're searching.

Convatec Group

LSE:CTEC GB00BD3VFW73
61
  • Value
    23
  • Growth
    33
  • Safety
    Safety
    64
  • Combined
    12
  • Sentiment
    96
  • 360° View
    360° View
    61
Unlock
Which ranks are driving this 360° View?
Subscribe to View
Company Description

Convatec Group Plc is a medical products and technologies company. It operates in the medical products and technologies industry, with a focus on solutions for chronic conditions, including Advanced Wound Care, Ostomy Care, Continence Care, and Infusion Care. The company markets and sells its solutions and services globally. In the last fiscal year, the company had a market cap of $6,659 million, profits of $1,299 million, and revenue of $2,289 million with 10,483 employees.

more
Analysis

ANALYSIS: With an Obermatt 360° View of 61 (better than 61% compared with alternatives), overall professional sentiment and financial characteristics for the stock Convatec Group are above average. The 360° View is based on consolidating four consolidated indicators, with half the metrics below and half above average for Convatec Group. The consolidated Value Rank has an attractive rank of 64, which means that the share price of Convatec Group is on the lower side compared with the typical size in indicators such as revenues, profits, and invested capital. This means that the stock price is lower than for 64% of alternative stocks in the same industry. The consolidated Sentiment Rank has a good rank of 96, which means that professional investors are more optimistic about the stock than for 96% of alternative investment opportunities. But the consolidated Growth Rank has a low rank of 33, which means that the company exhibits below-average growth momentum when looking at financial metrics such as revenue, profit, invested capital growth, and stock returns. The consolidated Safety Rank has a riskier rank of 23, meaning the company has a riskier financing structure than 77 comparable companies when looking at the amount of its debt, its refinancing requirements, and its ability to service debt. ...read more

more
Index
FTSE All Shares
FTSE 250
FTSE 350
Human Rights
The higher the 360° View, the better the stock performed against its peers, considering all metrics. The 360° View represents an average of the other 5 ranks and is then scaled to a rank from 1 to 100. The shaded values are illustrative only.
Last update: 21-Aug-2025.

Make Sense of the Ranks

The higher, the better. For every stock, we judge its performance against its peers and rank it on a scale of 1 to 100. These ranks are percentiles: a rank of 75 means the company outperforms 75% of its peers in that specific area. The higher the rank, the better the stock stacks up against its peers.

Detailed and Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history. Unlock the analysis.

Unlock Ranks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
64 60 53 87
Growth
33 10 29 7
Safety
Safety
23 19 8 39
Sentiment
96 80 85 66
360° View
360° View
61 32 30 51
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Analyst Opinions
83 75 82 38
Opinions Change
65 53 46 50
Pro Holdings
n/a 92 54 90
Market Pulse
64 51 74 40
Sentiment
96 80 85 66
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
64 60 53 87
Growth
33 10 29 7
Safety Safety
23 19 8 39
Combined
12 1 10 33
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Price vs. Sales (P/S)
64 56 50 78
Price vs. Earnings (P/E)
50 49 48 78
Price vs. Book (P/B)
25 22 16 73
Dividend Yield
79 75 74 65
Value
64 60 53 87
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Revenue Growth
36 4 26 17
Profit Growth
63 45 52 16
Capital Growth
18 25 16 34
Stock Returns
53 54 65 25
Growth
33 10 29 7
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Leverage
28 23 26 18
Refinancing
39 34 23 69
Liquidity
29 32 28 33
Safety Safety
23 19 8 39

Similar Stocks

Discover high‑ranked alternatives to Convatec Group and broaden your portfolio horizons.

Drägerwerk

XTRA:DRW3
Country: Germany
Industry: Health Care Equipment
Size: Medium
Full Stock Analysis

Schroders

LSE:SDR
Country: United Kingdom
Industry: Asset Management & Custody
Size: Large
Full Stock Analysis

Barratt Developments

LSE:BDEV
Country: United Kingdom
Industry: Homebuilding
Size: Medium
Full Stock Analysis

SSE

LSE:SSE
Country: United Kingdom
Industry: Electric Utilities
Size: X-Large
Full Stock Analysis

The Obermatt Advantage

Ready to Elevate Your Investing?
Get Started Today

Choose the Obermatt subscription that best fits your needs.


30-day money back guarantee. Your subscription will renew until you cancel it, which you can do at any time.